PMC7141926_01
Prior to treatment with topical INFa-2b. The lesion affects approximately 180o of the superior conjunctiva and cornea, and it partially invades the pupil
RomJOphthalmol-64-62-g001.jpg
PMC7141926_01_RomJOphthalmol-64-62-g001.jpg
F1
On exploration, the RE presented a fleshy, leukoplakia, over elevated and vascularized lesion, extending approximately over the 180o superior limbus and superior conjunctiva (from IX to III) that invaded part of the pupil (Fig. 1).
One month after topical treatment with INFa-2b. The lesion has significantly reduced in size and thickness, conjunctival leukoplakia has regressed, and pupillary axis was not affected
RomJOphthalmol-64-62-g002.jpg
PMC7141926_01_RomJOphthalmol-64-62-g002.jpg
F2
One month after treatment, the gelatinous and leukoplakia lesion diminished, showing flattening and regression of the vascularization (Fig. 2).
Six months after the initial treatment with topical INFa-2b. The lesion has disappeared
RomJOphthalmol-64-62-g003.jpg
PMC7141926_01_RomJOphthalmol-64-62-g003.jpg
F3
Given the satisfactory response to IFN-alpha-2beta, the treatment was continued up to six months of follow up, after which a complete remission of the lesion was noted (Fig. 3).